USP25 and bacterial infectious disease: Accordingly, Wang et al. found that in a mouse model, AZ1 was able to impair USP25-induced bacterial infection in the intestine and to enhance the immune response, while inhibiting the role of USP25 in the promotion of intestinal cancer (Wang et al., 2020b).